Clinical Trial Update: A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension [Phase 3]

View source ↗

Summary

Phase 3 open-label extension study of ralinepag in pulmonary arterial hypertension is ongoing, with enrollment by invitation to assess long-term efficacy and sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Pulmonary Hypertension

Drugs mentioned

• Ralinepag (ralinepag)

Snippet

Sponsor: United Therapeutics | Conditions: PAH, Pulmonary Hypertension | Phase 3 | Status: ENROLLING_BY_INVITATION